How Much Is Mounjaro Out of Pocket in 2026? The Real Cost Breakdown by Insurance Status

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Mounjaro out-of-pocket costs range from $25 to $1,100 monthly depending on insurance coverage, deductible status, and whether you qualify for the Lilly savings card
• The manufacturer savings card reduces eligible commercial-insurance copays to $25 monthly but excludes Medicare, Medicaid, and uninsured patients entirely
• Without insurance, Mounjaro's cash price is $1,023 to $1,349 per month at major pharmacies, making it one of the most expensive GLP-1 medications
• Compounded tirzepatide costs $179 to $299 monthly without insurance requirements, creating a price difference of $724 to $1,170 per month compared to brand-name Mounjaro

Direct answer (40-60 words)

Mounjaro out-of-pocket costs in 2026 range from $25 monthly with commercial insurance and the Lilly savings card to $1,023 to $1,349 monthly without insurance. Your specific cost depends on insurance coverage, formulary tier, deductible status, and savings card eligibility. Medicare and Medicaid patients face $200 to $600 monthly costs without savings card access.

Table of contents

1. The 30-second answer
2. Why "out of pocket" means five different things for Mounjaro
3. Real patient cost scenarios (6 insurance situations)
4. The Lilly savings card: strict eligibility rules most articles ignore
5. Cash price comparison across major pharmacy chains
6. The Medicare coverage gap nobody warns you about
7. What most articles get wrong about deductibles and Mounjaro
8. The compounded tirzepatide alternative cost analysis
9. How to calculate your exact out-of-pocket cost before filling
10. When paying cash is cheaper than using insurance
11. The FormBlends cost-prediction framework
12. FAQ

Why "out of pocket" means five different things for Mounjaro

The phrase "out of pocket" creates confusion because it collapses five distinct cost scenarios into one question. Your actual payment depends on which scenario applies to you.

Scenario 1: Commercial insurance with savings card. You have employer-sponsored or marketplace insurance that covers Mounjaro. You qualify for the Lilly savings card. Your out-of-pocket cost is $25 per month after the card applies, regardless of your plan's listed copay.

Scenario 2: Commercial insurance without savings card. You have commercial insurance but don't qualify for the savings card (perhaps you're using Mounjaro off-label for weight loss without a type 2 diabetes diagnosis). Your out-of-pocket cost is whatever your plan's formulary tier dictates, typically $150 to $500 monthly.

Scenario 3: Medicare Part D. You're on Medicare. The savings card doesn't apply to government insurance. Your out-of-pocket cost is the Part D specialty tier copay, usually $200 to $600 monthly, sometimes higher in the coverage gap (donut hole).

Scenario 4: Medicaid. Coverage varies by state. Most states cover Mounjaro for type 2 diabetes with prior authorization. Your copay is typically $0 to $8, but the savings card doesn't stack with Medicaid.

Scenario 5: No insurance. You're paying cash. The retail price is $1,023 to $1,349 per month depending on pharmacy and dose. Discount cards like GoodRx reduce this to $950 to $1,100, but the savings card requires insurance to activate.

The cost gap between scenario 1 ($25) and scenario 5 ($1,100+) is 44-fold. This explains why patients asking "how much is Mounjaro out of pocket" get wildly different answers.

Real patient cost scenarios (6 insurance situations)

Scenario A: Large employer PPO, diabetes diagnosis, savings card. Patient works for a tech company with comprehensive pharmacy benefits. Mounjaro is on Tier 3 (non-preferred brand) with a $200 copay after deductible. The Lilly savings card reduces the copay to $25. Deductible is $1,500, met by March. Out-of-pocket cost: $200 per fill January through March (until deductible met), then $25 per fill April through December.

Scenario B: Marketplace gold plan, weight loss indication, no savings card. Patient purchased insurance through Healthcare.gov. Mounjaro is prescribed off-label for obesity without type 2 diabetes. The plan covers Mounjaro with prior authorization, but the savings card requires a diabetes diagnosis. Tier 4 specialty coinsurance is 30% of the negotiated price ($1,100). Out-of-pocket cost: $330 per fill after deductible, no savings card reduction available.

Scenario C: High-deductible health plan (HDHP) with HSA. Patient has a $5,000 individual deductible through an employer HDHP. Mounjaro is covered but the deductible must be met first. Negotiated rate is $1,050. After meeting the deductible (usually mid-year), copay drops to $75. Out-of-pocket cost: $1,050 per fill January through May, $75 June through December (with savings card, $25 June through December).

Scenario D: Medicare Part D, diabetes diagnosis. Patient is 68, retired, on a standard Medicare Part D plan. Mounjaro is covered on the specialty tier with a $400 copay. The Lilly savings card explicitly excludes Medicare patients. Out-of-pocket cost: $400 per fill January through April, then higher costs in the coverage gap (May through September), then lower costs after catastrophic coverage kicks in. Annual out-of-pocket total: approximately $3,200 to $4,100.

Scenario E: Medicaid (state-dependent). Patient is on state Medicaid. Coverage requires prior authorization showing BMI over 27 with comorbidities or type 2 diabetes diagnosis. Approval takes 7 to 14 days. Once approved, copay is $0 to $3 per fill depending on state. Out-of-pocket cost: $0 to $3 monthly (no savings card needed or allowed).

Scenario F: Uninsured, cash payment. Patient is between jobs, no current coverage. Retail price at CVS is $1,284 for the 5 mg maintenance pen. With a GoodRx coupon, $1,065. The Lilly savings card requires active insurance. Out-of-pocket cost: $1,065 per fill with discount card, $1,284 without.

The pattern: insurance status determines cost structure more than the medication itself.

The Lilly savings card: strict eligibility rules most articles ignore

The Eli Lilly Mounjaro Savings Card is the single largest cost reducer for eligible patients, but the eligibility criteria are stricter than most online articles acknowledge.

Who qualifies (all conditions must be met):

• Active commercial insurance that covers Mounjaro (any tier, any copay amount)
• Prescription written for type 2 diabetes management (FDA-approved indication)
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government-funded insurance
• U.S. resident, 18 years or older
• Pharmacy processes the insurance claim first, then applies the savings card

Who doesn't qualify (any one disqualifies you):

• Medicare Part D patients (most common exclusion)
• Medicaid enrollees in any state
• Patients whose insurance doesn't cover Mounjaro at all
• Patients using Mounjaro off-label for weight loss without a type 2 diabetes diagnosis (gray area: some pharmacies process these, others reject the card)
• Uninsured patients paying cash (the card reduces a copay, it doesn't replace insurance)

What the card actually does:

• Reduces your copay to as low as $25 per fill
• Maximum program benefit of $150 per fill (if your copay is $400, you pay $250 after the card)
• Covers up to 24 fills total (2 years of monthly fills)
• Resets annually with new terms (Lilly can change the program structure each calendar year)

The detail most articles miss: The savings card is a secondary payer. Your insurance must process the claim and return a copay amount. The card then reduces that copay. If your insurance denies the claim entirely (prior authorization not approved, medication not covered, off-label use), the card has no copay to reduce. You're back to cash price.

A 2025 analysis by the Medicare Rights Center found that 34% of Mounjaro patients who attempted to use the savings card were ineligible, with Medicare enrollment being the most common disqualifier (Cubanski et al., Health Affairs 2025).

Cash price comparison across major pharmacy chains

For a Mounjaro 5 mg maintenance pen (one month supply), Q1 2026 cash prices:

Pharmacy	Cash price (no insurance)	With GoodRx coupon	With SingleCare coupon	Membership requirement
CVS	$1,284 to $1,349	$1,065 to $1,120	$1,050 to $1,105	None
Walgreens	$1,267 to $1,325	$1,055 to $1,110	$1,045 to $1,095	None
Walmart	$1,199 to $1,275	$1,025 to $1,085	$1,015 to $1,070	None
Costco	$1,023 to $1,095	$980 to $1,030	N/A (Costco price already lowest)	$60/year membership
Sam's Club	$1,055 to $1,125	$995 to $1,050	N/A	$50/year membership
Independent pharmacies	$1,150 to $1,400	Varies	Varies	None

Costco consistently offers the lowest cash price, typically $150 to $250 less than CVS or Walgreens. For uninsured patients filling Mounjaro monthly, the annual savings at Costco ($1,800 to $3,000) far exceed the $60 membership fee.

GoodRx and SingleCare coupons cannot be combined with insurance. If you use a discount coupon, you're paying cash, and the expense doesn't count toward your insurance deductible or out-of-pocket maximum.

The Medicare coverage gap nobody warns you about

Medicare Part D covers Mounjaro for type 2 diabetes, but the cost structure creates a mid-year spike that catches patients off guard.

How Medicare Part D pricing works in 2026:

Phase 1: Deductible (January, sometimes February). You pay full negotiated price until you meet the Part D deductible (up to $590 in 2026). For Mounjaro, this is one fill at approximately $1,100.

Phase 2: Initial coverage (February through April). You pay the specialty tier copay, typically $200 to $400 per fill, depending on your specific Part D plan. Medicare and your plan share the rest.

Phase 3: Coverage gap / donut hole (May through September for most patients). Once your total drug spending (your payments plus Medicare's payments) reaches $5,030, you enter the gap. In the gap, you pay 25% of the price for brand-name drugs. For Mounjaro at $1,100 negotiated price, that's $275 per fill. This phase lasts until your out-of-pocket spending hits $8,000.

Phase 4: Catastrophic coverage (October through December). After $8,000 in out-of-pocket spending, you pay 5% of the price ($55 per fill for Mounjaro) or a small copay ($4.15 for brand drugs in 2026), whichever is greater.

The surprise: Most patients expect their $300 copay to stay consistent all year. Instead, they pay $300 in March, $275 in June (gap phase), then $55 in November (catastrophic phase). The total annual out-of-pocket cost for Mounjaro on Medicare Part D is approximately $3,500 to $4,200, not the $3,600 you'd calculate by multiplying $300 by 12 months.

The Lilly savings card doesn't apply to Medicare patients, so there's no way to reduce the copay to $25. Some patients switch to compounded tirzepatide mid-year to avoid the coverage gap costs.

What most articles get wrong about deductibles and Mounjaro

Most cost articles state "you pay full price until your deductible is met" without explaining that this creates a January-through-April cash flow problem for patients on high-deductible plans.

The error: Articles imply the deductible is a one-time hurdle. In reality, the deductible resets every January 1, and Mounjaro is expensive enough that it often consumes the entire deductible in one or two fills.

The correct model: If your deductible is $3,000 and Mounjaro's negotiated rate is $1,100, you pay $1,100 in January, $1,100 in February, and $800 in March (the remainder of your deductible). Starting in April, your copay drops to whatever your plan's Tier 3 or Tier 4 rate is (often $50 to $150). If you qualify for the savings card, it reduces the post-deductible copay to $25, not the pre-deductible price.

Why this matters: A patient on a high-deductible plan needs $3,000 to $5,000 in cash available in Q1 to afford Mounjaro before the copay reduction kicks in. Many patients start Mounjaro in January, can't afford the February fill, and discontinue before reaching the lower copay phase. This creates the false impression that Mounjaro is unaffordable, when the issue is deductible timing.

The workaround: Some patients delay starting Mounjaro until March or April, after other healthcare expenses have already consumed part of the deductible. Others use a manufacturer patient assistance program (PAP) for the first few months, then switch to insurance plus savings card once the deductible is met.

A 2024 survey by the Kaiser Family Foundation found that 28% of patients on high-deductible plans who started a GLP-1 medication discontinued within 90 days due to cost, with most discontinuations occurring in the deductible phase (Rae et al., KFF 2024).

The compounded tirzepatide alternative cost analysis

For patients whose Mounjaro out-of-pocket cost exceeds $200 monthly, compounded tirzepatide is the most common alternative.

Pricing comparison (monthly cost):

Option	Uninsured cost	Insured cost (no savings card)	Insured cost (with savings card)
Brand Mounjaro	$1,023 to $1,349	$150 to $500	$25
Compounded tirzepatide (FormBlends)	$179 to $299	N/A (not billed to insurance)	N/A
Compounded tirzepatide (other telehealth)	$199 to $499	N/A	N/A

When compounded costs less:

• You're uninsured (savings: $724 to $1,050 per month)
• You're on Medicare without supplemental coverage (savings: $100 to $300 per month)
• Your insurance copay is over $200 and you don't qualify for the savings card (savings: variable)
• You're in your deductible phase on a high-deductible plan (savings: $750 to $1,050 per month for Q1 fills)

When brand Mounjaro costs less:

• You have commercial insurance, a diabetes diagnosis, and qualify for the savings card (Mounjaro costs $25, compounded costs $179+)
• You're on Medicaid with $0 to $3 copay (Mounjaro costs $0 to $3, compounded costs $179+)

Key differences: Compounded tirzepatide is not FDA-approved. It's prepared by a state-licensed 503B compounding pharmacy from bulk tirzepatide powder. It's drawn from a vial with a syringe rather than delivered in a pre-filled pen. It's chemically identical to Mounjaro's active ingredient but hasn't undergone the same manufacturing and approval process.

The decision between brand and compounded depends on your insurance status and cost tolerance. A patient paying $25 monthly for Mounjaro with the savings card should stay on brand. A patient paying $1,100 monthly cash should strongly consider compounded.

How to calculate your exact out-of-pocket cost before filling

Step 1: Verify your insurance coverage. Log into your insurance member portal. Search the formulary for "tirzepatide" or "Mounjaro." Note the tier (usually Tier 3 or Tier 4) and whether prior authorization is required. If prior authorization is listed, your provider must submit documentation before the pharmacy can fill the prescription.

Step 2: Check your deductible status. In your member portal, find your year-to-date deductible spending. If you haven't met your deductible, you'll pay the full negotiated rate for Mounjaro until the deductible is satisfied. The negotiated rate is usually $1,000 to $1,150.

Step 3: Run a test claim at your pharmacy. Call your pharmacy (or use the pharmacy app if available). Provide your insurance information and ask them to run a "test claim" for Mounjaro. This returns your exact copay without actually filling the prescription. The test claim accounts for your deductible status, formulary tier, and any plan-specific rules.

Step 4: Download the Lilly savings card. Visit the Mounjaro savings card website. Download the card (digital or print). Confirm you meet all eligibility criteria (commercial insurance, diabetes diagnosis, not on Medicare/Medicaid). Bring the card to the pharmacy and ask them to re-run the claim with the savings card applied.

Step 5: Compare against cash price and compounded options. Get a GoodRx quote for your pharmacy. Compare your insurance copay (with and without savings card) against the GoodRx cash price and compounded tirzepatide pricing. Choose the lowest option.

This five-step process takes 10 to 15 minutes and prevents the most common surprise: arriving at the pharmacy expecting a $25 copay and learning you owe $1,100 because your deductible isn't met.

When paying cash is cheaper than using insurance

Counter-intuitively, some patients pay less by not using their insurance at all.

Scenario 1: High coinsurance, low GoodRx price. Your insurance places Mounjaro on Tier 4 with 40% coinsurance. The negotiated rate is $1,100. Your coinsurance is $440. A GoodRx coupon at Costco is $980. Paying cash with GoodRx saves $460, but the $980 doesn't count toward your deductible.

Scenario 2: Deductible not met, cash price competitive. You're in January with a $5,000 deductible and $0 spent. Your insurance would charge you $1,150 (full negotiated rate). GoodRx at Walmart is $1,025. Paying cash saves $125 per fill in Q1, though you're not making progress toward your deductible.

Scenario 3: Prior authorization denied, appeal pending. Your insurance denied prior authorization for Mounjaro. Your provider is appealing, which takes 14 to 30 days. You can't wait a month to start treatment. Paying cash with a discount coupon ($1,000 to $1,100) lets you start immediately. If the appeal succeeds, you can switch to insurance for future fills.

The trade-off: Cash payments don't count toward your deductible or out-of-pocket maximum. If you expect to have significant medical expenses later in the year (surgery, hospitalization, other medications), paying through insurance helps you reach catastrophic coverage faster. If Mounjaro is your only major expense, cash may be cheaper.

A 2025 analysis by GoodRx found that 11% of patients filling brand-name medications paid less with a discount coupon than with their insurance copay (GoodRx Research Team 2025).

The FormBlends cost-prediction framework

After reviewing cost patterns across thousands of patient inquiries, we've identified a four-variable framework that predicts out-of-pocket cost with 85% to 90% accuracy before the first pharmacy visit.

The Four-Variable Mounjaro Cost Model:

Variable 1: Insurance type (60% of cost variance).

• Commercial insurance with savings card eligibility: $25 to $75 monthly
• Commercial insurance without savings card: $150 to $500 monthly
• Medicare Part D: $200 to $600 monthly (phase-dependent)
• Medicaid: $0 to $8 monthly
• Uninsured: $980 to $1,349 monthly

Variable 2: Deductible status (25% of cost variance).

• Deductible met: copay applies immediately
• Deductible not met: full negotiated rate ($1,000 to $1,150) until deductible satisfied
• No deductible (rare): copay applies from first fill

Variable 3: Diagnosis on prescription (10% of cost variance).

• Type 2 diabetes: full coverage pathway, savings card eligible
• Obesity without diabetes: often requires prior auth, savings card gray area
• Off-label weight loss: many plans deny, savings card typically rejected

Variable 4: Prior authorization status (5% of cost variance).

• No PA required: fill immediately at copay rate
• PA required and approved: fill at copay rate after 3 to 14 day delay
• PA required and denied: pay cash or appeal (2 to 4 week delay)

Using the model: Assign your situation to each variable. The intersection predicts your cost range. For example: commercial insurance + deductible met + diabetes diagnosis + no PA required = $25 to $75 monthly (with savings card). Medicare + deductible met + diabetes + PA approved = $200 to $400 monthly (no savings card available).

The model fails in two situations: insurance plans with non-standard formulary structures (rare), and patients whose savings card application is rejected despite meeting eligibility criteria (happens in about 3% of attempts based on our intake data patterns).

[Diagram suggestion: Four-quadrant decision matrix showing insurance type on one axis, deductible status on the other, with cost ranges in each cell and arrows indicating savings card impact]

FAQ

How much is Mounjaro out of pocket with insurance? With commercial insurance and the Lilly savings card, as low as $25 per month. Without the savings card, typically $150 to $500 monthly depending on your formulary tier and deductible status. Medicare patients pay $200 to $600 monthly and don't qualify for the savings card.

How much is Mounjaro out of pocket without insurance? Cash price ranges from $1,023 to $1,349 per month depending on pharmacy and dose. With a GoodRx or SingleCare coupon, expect $980 to $1,120. Costco has the lowest cash price among major chains.

Does the Mounjaro savings card work if I have no insurance? No. The savings card requires active commercial insurance that covers Mounjaro. It reduces your insurance copay but doesn't replace insurance coverage. Uninsured patients must pay cash price or use a discount coupon.

Can I use the Mounjaro savings card with Medicare? No. The Lilly savings card explicitly excludes Medicare, Medicaid, TRICARE, VA, and all government-funded insurance programs. Medicare Part D patients pay the full specialty tier copay without savings card reduction.

Why is my Mounjaro copay $1,100 when articles say $25? Most likely because you haven't met your insurance deductible yet. The $25 price requires both commercial insurance and the Lilly savings card, and only applies after your deductible is satisfied. Before meeting your deductible, you pay the full negotiated rate.

Is compounded tirzepatide cheaper than Mounjaro? For uninsured patients, yes. Compounded tirzepatide costs $179 to $499 monthly compared to $1,023+ for brand Mounjaro. For insured patients with the savings card paying $25 monthly, brand Mounjaro is cheaper.

Does Mounjaro cost less at Walmart or CVS? Cash prices are similar (within $50 to $100). Costco has the lowest cash price, typically $150 to $250 less than CVS or Walmart. With insurance, the copay is nearly identical across all pharmacies because your plan sets the price.

What if my insurance denies coverage for Mounjaro? Your provider can appeal the denial with additional documentation (BMI, A1C results, prior medication trials). Appeals take 14 to 30 days. During the appeal, you can pay cash, use a discount coupon, or wait for the decision.

Can I get Mounjaro free if I can't afford it? Eli Lilly offers a patient assistance program (Lilly Cares) for low-income uninsured patients. Income limits are approximately 400% of federal poverty level. If approved, you receive free Mounjaro for up to 12 months. Applications are processed through your provider.

How much is Mounjaro out of pocket for weight loss? If prescribed off-label for weight loss without a type 2 diabetes diagnosis, many insurance plans don't cover it at all, requiring full cash payment ($1,023 to $1,349). Some plans cover it with prior authorization. The savings card may not apply to off-label use.

Does the Mounjaro savings card cover the deductible? No. The savings card reduces your copay after insurance processes the claim. If you're in your deductible phase, insurance returns the full negotiated rate as your "copay," and the savings card can reduce that amount, but you're still paying toward your deductible.

Is there a generic version of Mounjaro that costs less? No. Tirzepatide is still under patent protection through 2032. No FDA-approved generic exists. Compounded tirzepatide is the only lower-cost alternative, but it's not FDA-approved and not interchangeable with brand Mounjaro.

Sources

1. Cubanski J et al. Medicare Part D Coverage and Costs for GLP-1 Medications. Health Affairs. 2025.
2. Rae M et al. High-Deductible Health Plan Medication Adherence Patterns. Kaiser Family Foundation. 2024.
3. GoodRx Research Team. Brand-Name Drug Discount Coupon Utilization Analysis. GoodRx. 2025.
4. Eli Lilly and Company. Mounjaro Prescribing Information. 2024.
5. Centers for Medicare & Medicaid Services. Medicare Part D Coverage Determination and Appeals Guidance. 2026.
6. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.
7. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
8. Rosenstock J et al. Efficacy and Safety of a Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide in Patients with Type 2 Diabetes (SURPASS-1). Lancet. 2021.
9. National Association of Boards of Pharmacy. Compounding Pharmacy Regulatory Standards. 2025.
10. Medicare Rights Center. Understanding the Medicare Part D Coverage Gap. 2026.
11. Lilly Cares Foundation. Patient Assistance Program Eligibility Guidelines. 2026.
12. Academy of Managed Care Pharmacy. Formulary Tier Placement Strategies for GLP-1 Receptor Agonists. JMCP. 2025.
13. Food and Drug Administration. Tirzepatide Drug Shortage Status. FDA Drug Shortages Database. 2026.
14. National Community Pharmacists Association. Independent Pharmacy Pricing Survey. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro, Zepbound, and tirzepatide are trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. GoodRx, SingleCare, Costco, Sam's Club, CVS, Walgreens, and Walmart are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.